MACK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 May 2024 @ 16:00):

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Stats
Today's Volume	310 023
Average Volume	136 531
Market Cap	217.69M
EPS	$0 ( 2024-03-14 )
Next earnings date	( $0 ) 2024-05-02
Last Dividend	$0.500 ( 2019-12-13 )
Next Dividend	$0 ( N/A )
P/E	-187.25
ATR14	$0.00200 (0.01%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-28	Andersen Eric	Buy	857	Common Stock
2023-12-26	Andersen Eric	Buy	48 693	Common Stock
2023-12-07	Andersen Eric	Buy	76 384	Common Stock
2023-12-07	Andersen Eric	Buy	24 666	Common Stock
2023-11-17	Andersen Eric	Buy	235	Common Stock

INSIDER POWER
99.80
Last 100 transactions
Buy: 1 159 920 \| Sell: 7 000

Volume Correlation

Long: 0.14 (neutral)

Short: 0.77 (moderate)

Signal:(51.011) Neutral

Merrimack Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Merrimack Pharmaceuticals Correlation - Currency/Commodity

-0.11
( neutral )

0.15
( neutral )

0.00
( neutral )

-0.52
( weak negative )

Merrimack Pharmaceuticals Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.0826

FY	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.0826

FY	2022
Revenue:	$0
Gross Profit:	$-445 000 (0.00 %)
EPS:	$-0.110

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.180

Financial Reports:

No articles found.

Merrimack Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Merrimack Pharmaceuticals Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$8.30	2017-05-30
Last Dividend	$0.500	2019-12-13
Next Dividend	$0	N/A
Payout Date	2019-12-23
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	$10.30	--
Avg. Dividend % Per Year	0.00%	--
Score	0.23	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2025-09-03)

$0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

0.23

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2017	$8.30	26.40%
2018	$0	0.00%
2019	$1.997	62.60%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-0.0524	1.200	-1.746	-2.10	[0 - 0.3]
returnOnEquityTTM	-0.0531	1.500	-1.701	-2.55	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	43.50	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	42.80	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	13.58	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.106	2.00	-0.0354	-0.0708	[0 - 30]
freeCashFlowPerShareTTM	-0.106	2.00	-0.0531	-0.106	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				0.695

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-210.30	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.0531	2.50	-1.093	-2.55	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.106	2.00	-0.0354	-0.106	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.106	2.00	-0.0354	-0.0708	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-1.537

Merrimack Pharmaceuticals